WO2007112679A1 - Nanoparticules de fibroïne de soie fixées par enzyme et procédé de production correspondant - Google Patents

Nanoparticules de fibroïne de soie fixées par enzyme et procédé de production correspondant Download PDF

Info

Publication number
WO2007112679A1
WO2007112679A1 PCT/CN2007/001032 CN2007001032W WO2007112679A1 WO 2007112679 A1 WO2007112679 A1 WO 2007112679A1 CN 2007001032 W CN2007001032 W CN 2007001032W WO 2007112679 A1 WO2007112679 A1 WO 2007112679A1
Authority
WO
WIPO (PCT)
Prior art keywords
enzyme
silk fibroin
immobilized
organic solvent
water
Prior art date
Application number
PCT/CN2007/001032
Other languages
English (en)
Chinese (zh)
Inventor
Yuqing Zhang
Original Assignee
Yuqing Zhang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuqing Zhang filed Critical Yuqing Zhang
Publication of WO2007112679A1 publication Critical patent/WO2007112679A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes

Definitions

  • the invention discloses an immobilized enzyme carrier and a preparation method thereof, in particular to a silk fibroin nanoparticle prepared by using silk fibroin to produce an immobilized enzyme and a preparation method thereof, belonging to the field of biotechnology enzyme engineering, and also belonging to the field of nanotechnology. And the field of polymer chemistry technology. Background technique
  • the enzyme or drug into the body in the form of microparticles, microcapsules, liposomes, albumin, red blood cell carrier, etc. can prolong the half-life of the enzyme or drug, and release it slowly, extracting the enzyme or drug for hereditary enzyme deficiency, metabolism Therapeutic effects of disorders, tumors, and cardiovascular diseases.
  • the use of natural biomaterials as an enzyme-immobilized carrier or as a sustained-release carrier for drugs has been studied because of its safety, stability, biocompatibility and metabolism in the body.
  • the silk fibroin produced by silkworm is a natural terpene molecular polymer with a molecular weight of up to 370,000.
  • this protein is non-toxic, harmless, and non-immunological to humans, it has long been used as a surgical suture.
  • development and utilization of silk fibroin in raw materials for artificial skin, cosmetics, and nutritious foods, or as carriers for immobilized cells, enzymes, and antibodies have been attracting attention.
  • studies using silk fibroin as an immobilized enzyme carrier have been particularly active over the past two decades, and many experiments have fully confirmed that silk fibroin is an excellent immobilized enzyme biomaterial.
  • Silk fibroin as an enzyme immobilization carrier has advantages not found in other polymer materials.
  • the principle of enzyme immobilization is based on the antiparallel of silk fibroin from soluble random coils and (X-helix structure to insoluble) The ⁇ -sheet structure, at the same time, completes the immobilization of the enzyme.
  • Silk fibroin is used as an immobilized enzyme carrier in various forms such as silk fibroin film, silk fibroin fiber, silk fibroin powder or silk fibroin gel.
  • the preparation and application research is very active, and there have been a large number of patent reports, mainly through the physical or chemical methods to induce silk fibroin condensation such as salting out, ultrasonic, aeration, high-speed stirring, isoelectric point condensation, electrolysis or prior
  • silk fibroin condensation such as salting out, ultrasonic, aeration, high-speed stirring, isoelectric point condensation, electrolysis or prior
  • the ultrafine silk fibroin powder of 1 to 100 micrometers is prepared, and is widely used in cosmetics, nutraceuticals, additives, enamel water absorbing materials and coatings.
  • most of these methods or processing environments are not suitable for the preparation of immobilized enzymes with high activity and stable performance.
  • Fibre textbook Chinese Patent No. WO1560136 International Patent WO 2005085327 A1
  • Method for Producing Silk Fibro Nanoparticles discloses a method of mixing a water-soluble regenerated silk fibroin solution directly with an excess of a water-miscible organic solvent.
  • a preparation method of silk fibroin nanoparticles is prepared, but some organic solvents cause deactivation of the enzyme and are not suitable for preparing an immobilized enzyme.
  • the water-soluble silk fibroin and the enzyme mixture are prepared by salting out an inorganic salt or an inorganic salt and an organic salt mixture to prepare an immobilized enzyme (Japanese Patent, JP-A-JP56-15687; JP-A-JP60-155125, International Patent, WO8503230; Special opening JP62-151180); or the silk fibroin and enzyme mixture first adjusted to acidic or alkaline, and then salted out, washed, dried to form a powdered immobilized enzyme (Japanese Patent, Special Open JP56-051983, JP-A-JP56-39783).
  • a small amount of organic solvent such as methanol is added to directly induce the aggregation of silk fibroin, or the silk fibroin mixture is first adjusted to the vicinity of the isoelectric point of silk fibroin, and a small amount of organic solvent is added to induce the aggregation of silk fibroin, and then the condensation is performed. After washing, drying and pulverizing, it is made into immobilized ⁇ -starch and sucrase (Japanese Patent, JP-A-JP1-313530), or made into an immobilized alkaline or neutral protease (Japanese Patent, JP-A-JP56-18590) ).
  • the immobilized enzyme is produced by causing the silk fibroin and the enzyme mixture to generate a large amount of foam by agitation or inflating of the silk fibroin (Japanese Patent No. JP-A-60-227679, JP-A-61-187790).
  • the mixture of silk fibroin and enzyme is first frozen and then thawed to denature the silk fibroin to prepare an immobilized alkaline phosphatase (Japanese Patent Laid-Open No. JP 01-120287).
  • the silk fibroin powder is first prepared by salting out, and then the cross-linking agent is used to crosslink the silk fibroin powder with the saccharifying enzyme to prepare an immobilized enzyme powder [Sericulture Science, 25(2): 113-119, 1999 ].
  • immobilized enzymes using silk fibroin as a carrier at home and abroad. The reason for this is mainly because the silk fibroin powder prepared by the above methods has poor crystallinity, poor stability, small specific surface area, and low activity of immobilized enzyme.
  • the agglomerates or precipitates formed during the preparation process require drying and repeated pulverization and the like, and the silk fibroin powder thus prepared has a large particle size and a different shape, all of which are above the micron order.
  • the object of the present invention is to overcome the deficiencies of the prior art and to provide a silk fibroin nanoparticle having an immobilized enzyme having good biocompatibility, high enzymatic activity recovery rate and simple production process, and a preparation method thereof.
  • the technical scheme adopted by the invention is: providing an immobilized enzyme silk fibroin nanoparticle, which has silk fibroin as a core, the enzyme is embedded and fixed in the surface layer of the microparticle, and the average particle size is 35 ⁇ 125 ⁇ , insoluble in water;
  • the silk fibroin has a ⁇ -sheet structure and a crystallinity of 20% or more.
  • the method for preparing the above-mentioned immobilized enzyme silk fibroin nanoparticles uniformly mixing the water-soluble silk fibroin solution and the enzyme, and injecting the silk fibroin mixture into the rapidly stirring water-soluble organic solvent, the silk fibroin solution and the organic solvent
  • the mixing volume ratio is 1:2.3 or more, forming the milky silk fibroin as the core, and the spherical particles embedded in the surface layer and immobilized in the enzyme are dispersed in the organic solvent system to obtain the silk fibroin nanoparticle mixture or suspension of the immobilized enzyme, and then The organic solvent is removed to obtain a silk fibroin nanoparticle of the immobilized enzyme.
  • the water-soluble silk fibroin described in the above technical solution comprises purified from silk or wild silk, or silk fibroin produced by genetic engineering; the concentration of the silk fibroin solution is 0.1-20%.
  • the enzyme mixed with the silk fibroin solution described in the above technical means is one or a mixture of two or more of an oxidoreductase, a hydrolase and an isomerase.
  • the stirring speed is 50 rpm or more.
  • the water-soluble organic solvent is ethanol or acetone.
  • the method for producing the above-mentioned immobilized enzyme silk fibroin nanoparticles has a working environment temperature of 10 to 45 ° C, preferably 25 to 37 ° C.
  • the organic solvent mixture or suspension of the immobilized enzyme silk fibroin nanoparticles is subjected to repeated centrifugal dehydration treatment, or repeated filtration and washing treatment until the organic solvent is completely removed.
  • the obtained silk fibroin nanoparticles were added to pure water or an aqueous solution and then ultrasonicated for 1 to 10 minutes to prepare an immobilized enzyme nanosiltin solution.
  • the organic solvent mixture or suspension of the obtained immobilized enzyme silk fibroin nanoparticles is subjected to vacuum freeze-drying to prepare an immobilized enzyme nanosiltin powder.
  • Silk fibroin is also a high molecular egg White, when silk fibroin is made into regenerated water-soluble silk fibroin, it is susceptible to physical or chemical factors and protein denaturation occurs, especially when organic solvents are encountered, and structural changes are more likely to occur and coagulation precipitates.
  • a small amount of an organic solvent was added to a mixed solution of silk fibroin and an enzyme to cause the silk fibroin to coagulate or precipitate, the enzyme was embedded in the silk fibroin precipitate, and then dried and pulverized to prepare an immobilized enzyme.
  • the invention utilizes the two characteristics that the silk fibroin structure is susceptible to change and the water-soluble organic solvent easily causes protein denaturation, and a small amount of the mixed solution of silk fibroin and the enzyme is injected into a high-speed agitation of a large amount of pure organic solvent to promote silk fibroin. Rapid dispersion and denaturation, water-soluble silk fibroin is directly converted from ⁇ -helix and random coil into ⁇ -sheet structure, and while crystallized silk fibroin particles are formed, the enzyme is embedded and immobilized to obtain nano-scale properties. Stable, water-insoluble immobilized silk fibroin nanoparticles.
  • the present invention also finds that ethanol and acetone are more effective in immobilizing the enzyme. Therefore, a preferred technical solution is that the organic solvent is ethanol or acetone.
  • the present invention has the following advantages:
  • the obtained immobilized enzyme silk fibroin particles have an average of about 80 nm, and the enzyme activity recovery rate is up to 60%.
  • the electron microscope observation is spherical, the crystallinity is more than 20%, the performance is stable, and it is not easily decomposed by proteases, and has strong resistance to ultraviolet radiation. Function, in the body can greatly reduce or eliminate the immunogenicity of the enzyme, and extend the half-life of the enzyme.
  • the silk fibroin nanoparticle of the immobilized enzyme provided by the technical scheme of the present invention has good stability, and can be placed at room temperature for a long time in both the particle suspension and the lyophilized powder state, and the enzyme activity is not affected at all, and does not need to be pure.
  • the enzyme must be stored at 4 ⁇ or 4 ;.
  • the immobilized silk fibroin nanoparticles in the lyophilized powder state can be resistant to high temperatures, and the enzyme activity is not lost when dried at 90 to 100 ° C for 1 hour.
  • the obtained nanofilament of the immobilized enzyme is non-toxic, harmless, and has good biocompatibility, and is a green color.
  • the organic solvent such as ethanol or acetone is mixed with the silk fibroin solution to form a suspension of the milky white immobilized enzyme silk fibroin nanoparticle, which is filtered or centrifuged, and the discarded filtrate or supernatant can be recovered and re-steamed;
  • the aqueous solution of the organic solvent sublimed by vacuum freeze-drying can also be recovered and re-steamed and recycled. It also has a broad market prospect due to its simple product preparation process, low cost and low efficiency.
  • Figure 1 is a fluorescence emission spectrum of immobilized glucose oxidase silk fibroin nanoparticles obtained by the method of the present invention
  • Figure 2 is an infrared absorption spectrum of immobilized glucose oxidase silk fibroin nanoparticles obtained by the production method of Example 1 of the present invention
  • Figure 3 is an X-ray diffraction pattern of immobilized glucose oxidase silk fibroin nanoparticles obtained according to the manufacturing method of Example 1 of the present invention
  • Fig. 4 is a graph showing the particle size distribution of immobilized glucose oxidase silk fibroin nanoparticles obtained by the production method of Example 1 of the present invention. detailed description
  • Embodiment 1 is a diagrammatic representation of Embodiment 1:
  • the above-mentioned silk fibroin-removed silk fibroin fiber is mixed with 5 to 20 times (W/V) of 8-9 M lithium bromide aqueous solution or lithium bromide methanol water ternary mixed solvent, and dissolved at 40 ° C or higher for 2 to 40 hours; or
  • the silk fibroin is mixed with 5 to 20 times the calcium chloride/ethanol/water ternary mixed solvent (molar ratio 1: 2:8), and dissolved at 50 ⁇ or more for 1 to 5 hours; or the above silk fibroin
  • the fibers are dissolved in other concentrated salt solutions or organic solvents.
  • the various silk fibroin solutions obtained above are dialyzed, desalted, and purified to prepare a water-soluble silk fibroin solution having a concentration of 0.5 to 15%, preferably concentrated or diluted to a 1.5 to 3.5% water-soluble silk fibroin solution.
  • the acetone is rapidly denatured into ultrafine particles suspended in an organic solvent by rapidly adding an excess amount of acetone (final volume of 70% or more) under an environment of 25 to 37 °C.
  • the filtered immobilized enzyme silk fibroin wet powder is placed in a buffer solution, and after sonication, it becomes a suspension of immobilized glucose oxidase silk fibroin nanoparticles, which can be directly used for enzyme activity determination; or
  • the filtered immobilized enzyme silk fibroin wet powder was frozen at -20 Torr, and finally, vacuum freeze-dried to obtain powdery immobilized glucose oxidase silk fibroin nanoparticles.
  • the glucose oxidase activity was measured by a slightly improved method using a previously reported method (Kawahara Y: Journal of Sericulture Science of Japan, 62(4), 272-275, 1993).
  • the specific steps are as follows: Add 2.4ml staining buffer, 0.5mL 10% substrate glucose solution and 0.1ml peroxidase solution to the measuring tube, standard tube and blank tube, shake well, set at 37 °C constant temperature 2 ⁇ After 5 minutes, the reaction was started by adding the free enzyme. The blank tube was used as the control. The absorbance change of the reaction was measured at the wavelength of 500iun for 5 minutes. Then, except for 5, 1.0 mmol/L ⁇ -D-glucose was oxidized to D-gluconic acid per minute. And the absorbance value added by H 2 0 2 . When the immobilized enzyme is measured, the measurement of the silk fibroin particles in the colorimetric suit will block the transmission of the ultraviolet light and interfere with the measurement.
  • the immobilized enzyme reactor is prepared, and after the reaction is 5 m i, the filter is immediately filtered.
  • the reaction solution was measured to measure the absorbance value.
  • One unit of glucose oxidase activity was defined as 37 ° C, pH5.5 phosphate catalyst per minute 1.0 mmol / L ⁇ -D- glucose oxidase is under buffer conditions D- gluconic acid and H 2 0 2 produced an absorbance Change value.
  • the values in the table are the average of 5 replicates. As can be seen from the table, the activity recovery rate of the immobilized enzyme is between 24.5 and 72.9%.
  • Silk fibroin can be found in the picture After nanocrystallization, the fluorescence emission spectrum undergoes a blue shift of lOrnn, indicating that the silk fibroin molecules are converted from a random coil and an ⁇ -slow helix to a ⁇ -sheet structure.
  • immobilized glucose oxidase silk fibroin nanoparticle lyophilized powder and enzyme-containing water-soluble silk fibroin solution lyophilized powder were sampled with a few KBr pellets on a Magna 550 infrared spectrophotometer ( Nicolet Instrument Corp. USA) The measurement was performed on a scan range of 4000 to 200 cm - 1 .
  • the infrared absorption spectrum of the enzyme-containing water-soluble silk fibroin shows the characteristics of random coil and ⁇ -slow spiral or crank-shaped structure (Silk l). When the silk fibroin is nanosized, its absorption band is displaced, and antiparallel ⁇ appears. - The construction of the fold (Silk ll).
  • a silk fibroin sample was analyzed by a MERCURY CCD-AFC8 CCD single crystal X-ray diffractometer (Nippon Rigaku Corporation) with a tube voltage of 4.0 kV, a tube current of 35 mA, and a scanning speed of 2 °/min. Ni filtering.
  • the enzyme-containing water-soluble silk fibroin lyophilized powder can be confirmed as a completely amorphous structure, and after the silk fibroin is nanosized in acetone, the silk fibroin molecular conformation is converted from Silk l to Silk ll to become a crystalline immobilized enzyme silk fibroin nanoparticle. .
  • the immobilized glucose oxidase silk fibroin nanoparticles were diluted with water, sonicated and placed directly in a sample cup, and the particle size distribution was measured on a Zetasizer 3000HSa laser particle size analyzer (Malvern Instruments Ltd, Malvern UK).
  • the size of the silk fibroin nanoparticles of the immobilized enzyme is between 35 and 125 nm.
  • Embodiment 2 is a diagrammatic representation of Embodiment 1:
  • the activity of a solution enzyme or an immobilized enzyme was measured using a superoxide dismutase (SOD) assay kit (manufactured by Nanjing National Institute of Bioengineering, Division 1).
  • SOD superoxide dismutase
  • the method is determined by the xanthine and xanthine oxidase reaction system, the latter oxidizes hydroxylamine to form nitrite, which is purple-red under the action of a color developing agent, and the absorbance is measured by a Hitachi U3000 ultraviolet-visible spectrophotometer.
  • SOD superoxide dismutase
  • the absorbance value of the tube in the colorimetric measurement is lower than the absorbance value of the control tube.
  • the SOD activity (NU/mI, expressed in nitrite units) of the sample to be tested was calculated.
  • the activity of the immobilized enzyme activity in the table was calculated based on the activity of bovine blood superoxide dismutase (manufactured by Shanghai Oriental Livzon Biochemical Co., Ltd.) of 100%. The results showed that the activity of immobilized superoxide dismutase was between 25 and 79.4%.
  • Penicillin acylase EGicillin EG3.5.11
  • PABA P-dimethylaminobenzaldehyde
  • Penicillin acylase 100 O/mL at 37.
  • C cleavage of penicillin produces 6-APA under acidic conditions, which in turn forms Schiff base with PDAB and has maximum absorption at 415 nm.
  • the enzyme activity assay procedure is as follows: 0.5 ml of the enzyme solution or about 20 mg of the immobilized enzyme is added to 4.5 ml of phosphate buffer (pH 7.8) to be diluted. Pipette 1.0 ml into a test tube and equilibrate 5 m i at 37 °C. Another 4% penicillin G solution was equilibrated at 37 V for 5 min, and 1.0 ml was pipetted into the above enzyme-containing tube, shaken, accurately reacted for 5 min, and reacted by adding 3 ml of ethanol. Pipette 0.75 ml and add 5.25 ml of PDAB chromogenic solution for 3 min. The optical density was measured at 415 nm. The 6-APA concentration was obtained against the standard curve. The amount of enzyme required to catalyze the hydrolysis of penicillin G potassium salt per minute to produce 6- ⁇ of ⁇ at pH 7.8, temperature 37 °C, is defined as one enzyme unit (U).

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Zoology (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne des nanoparticules de fibroïne de soie fixées par enzyme, ainsi que le procédé de production correspondant. Ce procédé consiste (1) à mélanger complètement l'enzyme et une solution de fibroïne de soie régénérée, (2) à injecter le tout dans un solvant organique hydrosoluble avec une grande vitesse d'agitation, afin d'obtenir des nanoparticules de fibroïne de soie cristallines blanches fixées par l'enzyme, puis (3) à effectuer une centrifugation ou une filtration de manière à éliminer le solvant organique afin d'obtenir des nanoparticules de fibroïne de soie cristallines fixées par l'enzyme. La taille moyenne des nanoparticules est située entre 35 et 125 nm et la récupération d'activité s'élève à 70%. L'enzyme fixée présente une stabilité thermique élevée et n'est pas facile à décomposer avec une protéinase, ce qui permet de réduire fortement, voire de supprimer, l'immunogénicité de l'enzyme. Les nanoparticules fixées par l'enzyme s'utilisent largement dans le cadre d'une libération prolongée de médicament, dans un réacteur à enzyme industrielle, dans des additifs alimentaires et dans des produits cosmétiques.
PCT/CN2007/001032 2006-03-30 2007-03-29 Nanoparticules de fibroïne de soie fixées par enzyme et procédé de production correspondant WO2007112679A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB2006100391918A CN100427593C (zh) 2006-03-30 2006-03-30 固定化酶的丝素纳米颗粒及其制备方法
CN200610039191.8 2006-03-30

Publications (1)

Publication Number Publication Date
WO2007112679A1 true WO2007112679A1 (fr) 2007-10-11

Family

ID=37002137

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2007/001032 WO2007112679A1 (fr) 2006-03-30 2007-03-29 Nanoparticules de fibroïne de soie fixées par enzyme et procédé de production correspondant

Country Status (2)

Country Link
CN (1) CN100427593C (fr)
WO (1) WO2007112679A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011015652A1 (fr) 2009-08-07 2011-02-10 Novartis Ag Dérivés 3-hétéroarylméthyl-imidazo[1,2-b]pyridazin-6-yliques comme modulateurs de la tyrosine kinase c-met
WO2015048527A1 (fr) * 2013-09-27 2015-04-02 Tufts University Hydrogels de soie optiquement transparents
EP3444336A1 (fr) * 2017-08-18 2019-02-20 The Procter & Gamble Company Agent de nettoyage
CN111019932A (zh) * 2019-11-28 2020-04-17 湖南大学 磷酸铜-酶矿化材料的制备方法及其产品与应用
CN115715590A (zh) * 2022-11-18 2023-02-28 南昌大学 具有控释靶向性纳豆激酶-葛根素凝胶微球的制备方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101168763B (zh) * 2007-11-09 2011-07-13 重庆理工大学 一种纳米蚕丝丝素蛋白粉的制备方法
WO2014067933A1 (fr) * 2012-10-31 2014-05-08 C-Lecta Gmbh Préparation de support bioactif pour une sécurité améliorée dans les produits de soin et les aliments
CN106822038B (zh) * 2017-01-22 2020-08-07 厦门大学 一种包裹酶的蚕丝纳米小球的制备方法及其应用
AU2019255069A1 (en) * 2018-04-19 2020-11-26 Saraya Co., Ltd. Method and kit for assisting diagnosis of disease in subject
CN109337892B (zh) * 2018-11-27 2021-11-19 贺州学院 丝素固定芋头多酚氧化酶的方法
IT201900014607A1 (it) 2019-08-09 2021-02-09 Sapienza Univ Di Roma Nanofibroina e composizioni che la contengono per applicazioni in cosmetica

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5618590A (en) * 1979-07-20 1981-02-21 Kanebo Ltd Production of immobilized protease
JPH01313530A (ja) * 1988-06-10 1989-12-19 Terumo Corp 絹フイブロイン粉末の製法
CN1560136A (zh) * 2004-03-04 2005-01-05 苏州大学 纳米丝素颗粒的制造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5566929A (en) * 1978-11-13 1980-05-20 Kanebo Ltd Finely-powdered fibroin and its manufacture
JP3716392B2 (ja) * 2003-04-17 2005-11-16 福島県 野蚕または家蚕の絹フィブロイン粉末の製造方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5618590A (en) * 1979-07-20 1981-02-21 Kanebo Ltd Production of immobilized protease
JPH01313530A (ja) * 1988-06-10 1989-12-19 Terumo Corp 絹フイブロイン粉末の製法
CN1560136A (zh) * 2004-03-04 2005-01-05 苏州大学 纳米丝素颗粒的制造方法

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011015652A1 (fr) 2009-08-07 2011-02-10 Novartis Ag Dérivés 3-hétéroarylméthyl-imidazo[1,2-b]pyridazin-6-yliques comme modulateurs de la tyrosine kinase c-met
WO2015048527A1 (fr) * 2013-09-27 2015-04-02 Tufts University Hydrogels de soie optiquement transparents
US12049481B2 (en) 2013-09-27 2024-07-30 Tufts University Optically transparent silk hydrogels
EP3444336A1 (fr) * 2017-08-18 2019-02-20 The Procter & Gamble Company Agent de nettoyage
WO2019035038A1 (fr) * 2017-08-18 2019-02-21 The Procter & Gamble Company Agent de nettoyage
CN111019932A (zh) * 2019-11-28 2020-04-17 湖南大学 磷酸铜-酶矿化材料的制备方法及其产品与应用
CN111019932B (zh) * 2019-11-28 2023-11-14 湖南大学 磷酸铜-酶矿化材料的制备方法及其产品与应用
CN115715590A (zh) * 2022-11-18 2023-02-28 南昌大学 具有控释靶向性纳豆激酶-葛根素凝胶微球的制备方法
CN115715590B (zh) * 2022-11-18 2024-03-29 南昌大学 具有控释靶向性纳豆激酶-葛根素凝胶微球的制备方法

Also Published As

Publication number Publication date
CN1834240A (zh) 2006-09-20
CN100427593C (zh) 2008-10-22

Similar Documents

Publication Publication Date Title
WO2007112679A1 (fr) Nanoparticules de fibroïne de soie fixées par enzyme et procédé de production correspondant
Zhang et al. Formation of silk fibroin nanoparticles in water-miscible organic solvent and their characterization
CN108396023B (zh) 用研磨法制备磁性mof材料并用于酶的固定
Singh et al. Cicer α-galactosidase immobilization onto functionalized graphene nanosheets using response surface method and its applications
CN1243059C (zh) 纳米丝素颗粒的制造方法
CN108130321A (zh) 一种含蛋白酶-无机杂化纳米花的水凝胶及其制备方法和应用
CN110468120A (zh) 一种含漆酶的铜纳米花及其制备方法
Jafary et al. Stability improvement of immobilized alkaline phosphatase using chitosan nanoparticles
CN111438368B (zh) 利用丝素蛋白溶液制备金铂双金属纳米酶及其应用
Wang et al. Bioconjugation of silk fibroin nanoparticles with enzyme and peptide and their characterization
WO2021008171A1 (fr) Nanoparticules d'amidon amphiphile et procédé de préparation correspondant
Zhang et al. Highly efficient processing of silk fibroin nanoparticle-l-asparaginase bioconjugates and their characterization as a drug delivery system
JPS6320520B2 (fr)
CN102344686A (zh) 一种以聚乙烯醇为稳定剂的丝素蛋白纳米颗粒的制备方法
EP0133531A1 (fr) Immobilisation de biocatalyseurs
WO2020259018A1 (fr) Nanoparticule de catalase auto-assemblée, et son procédé de préparation et son utilisation
CN106939305A (zh) 一种表面活性剂‑酶纳米复合催化剂的制备方法与应用
CN114292904B (zh) 一种优化ctDNA检测准确率的方法
CN113604527A (zh) 一种限制性酶解制备的多肽纳米纤维及其制备方法与应用
CN107034206B (zh) 一种酶-凝集素结合物纳米颗粒及其制备方法
Rai et al. Development of recyclable magnetic cross-linked enzyme aggregates for the synthesis of high value rare sugar d-tagatose in aqueous phase catalysis
CN116462853B (zh) 一种Fe3O4@PMMA/PAMAM微球及其合成与固定化脂肪酶
CN103937775A (zh) 一种磁性交联酶聚集体及其制备方法和应用
Zhang et al. Immobilization of β-galactosidase on tamarind gum and chitosan composite microspheres
CN109852603A (zh) 一种含木瓜蛋白酶的铁-铜复合磁性纳米花及其制备方法和应用

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07720606

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07720606

Country of ref document: EP

Kind code of ref document: A1